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Abstract
Objective—To estimate the rate of vaginal birth after cesarean delivery (VBAC) success in diabetic
women based on White’s Classification.
Methods—This is a secondary analysis of an observational study conducted at 19 medical centers
of women attempting VBAC. Diabetic women with singleton gestations, one prior cesarean delivery,
and cephalic presentation who underwent a trial of labor (TOL) were included. VBAC success rates,
maternal and neonatal complications were compared based on White’s Classification.
Results—Of 11,856 women who underwent trial of labor, 624 met all study criteria (Class A1=356,
A2=169, B=70, C=21, D, R, or F=8). VBAC success in each group was: A1=68.5% (95% confidence
interval [CI] 63.4%–73.3%), A2=55% (95% CI 47.2%–62.7%), B=70% (95% CI 57.9%–80.4%),
C=47.6% (95% CI 25.7%–70.2%), D/F/R=12.5% (95% CI 0.3%–52.7%). Maternal and neonatal
complications were rare, and not found to be different between groups.
Conclusion—Our study provides estimates for VBAC success based on White’s classification and
indicates a relatively low rate of perinatal complications after VBAC attempt for diabetic women.
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More than a fourth of all births in the United States are by cesarean delivery (CD) (1). Attempts
to lower the CD rate have focused on encouraging vaginal birth after cesarean (VBAC). An
integral part of achieving a lower CD rate through better utilization of VBAC is predicting who
is not a good candidate for trial of VBAC (2).
The incidence of diabetes among American adults has increased from 4.9 percent in 1990 to
6.9 percent in 1999 (3). The lifetime risk of diabetes for an American female is approximately
39% (3). Prevalence of gestational diabetes in the United States is reported to be between 1.4
– 14% of pregnancies (4,5). More reproductive age women are being diagnosed with diabetes
than ever before, as the incidence of both pre-gestational and gestational diabetes is
approaching nearly 5% of all pregnancies (6).
Diabetic women are at increased risk for CD secondary to labor arrest, failed induction, and
fetal intolerance to labor (7,8). Furthermore, diabetic women have increased body mass index
and weight gain during pregnancy, both of which have a negative impact on VBAC success
(8). Large population-based studies have shown VBAC in the non-diabetic population to be a
reasonable option for the patient and provider who are motivated to avoid the maternal
morbidity associated with repeat CD (9). Currently, there is a paucity of data regarding VBAC
outcomes for diabetic women. Coleman et al showed that the VBAC success rate was lower
in gestational diabetics when compared to a non-diabetic population (10), while Grinstead et
al identified medical conditions, of which diabetes was included, to be a predictor of VBAC
failure (11). There is a relationship between increasing CD rates and severity of diabetes
(12). VBAC success rate based on disease severity has been examined previously, although
that study took place in a single center (13).
The purpose of this study was to estimate the rate of VBAC success in diabetic women by
White’s classification of diabetes in pregnancy (14). Secondary objectives included estimating
maternal and neonatal complication rates in diabetic women attempting VBAC.
Methods
This is a secondary analysis of a 4-year observational study conducted at 19 academic medical
centers of the Eunice Kennedy Shriver National Institute of Child Health and Human
Development Maternal–Fetal Medicine Units Network (NICHD-MFMU Network) between
1999 and 2002 (9). Details of the study design have been reported previously (9). Inclusion
criteria for this analysis were maternal diabetes, singleton gestation, one prior low-transverse
cesarean delivery, gestational age ≥ 370/7 weeks and a VBAC attempt. Women with
pregnancies complicated by fetal structural or chromosomal abnormalities were excluded.
Maternal demographic, clinical, and outcome data were abstracted from medical records charts
by trained research nurses. VBAC success was defined as VBAC attempt that ended in vaginal
delivery. A composite outcome of maternal complications which included uterine rupture,
uterine dehiscence, need for hysterectomy (by cesarean), deep vein thrombosis, need for
transfusion (intra/postop), and maternal death was reported. In a similar fashion, a composite
of neonatal complications, which included 5 minute Apgar < 4, umbilical artery pH < 7.0,
seizures (confirmed), hypoxic-ischemic encephalopathy, and neonatal death, was reported.
Maternal and neonatal characteristics and outcomes were stratified by White’s class (A1, A2,
B, C, or D/F/R)(14) and compared with the exact Cochran-Armitage test of trend (15).
Continuous variables were compared with the use of Wilcoxon rank-sum test and categorical
variables were compared with the use of chi-squared or Fisher’s exact test. Multivariable
logistic regression was used to adjusting for gestational age and labor induction for the primary
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outcome of successful VBAC. Nominal two-sided p values are reported with statistical
significance defined as a P value <0.05. No adjustment was considered for multiple
comparisons. SAS (SAS Institute, Cary, NC) was used for the analysis except the exact tests
and confidence intervals (Clopper-Pearson)(16), which were computed by Cytel Studio 8.
Approval for the original study was obtained at each of the originally participating institutions.
Approval for this secondary analysis was obtained from the University of Texas Health Science
Center in Houston Institutional Review Board.
Results
In the overall cohort 11,856 women underwent trial of labor. There were 1,358 women with
diabetes; 624 (45.9%) attempted VBAC. The rate of VBAC attempt by White’s class was:
48.7% for A1, 45.3% for A2, 44.9% for B, 33.3% for C, and 23.5% for D/F/R. Comparisons
of demographic and clinical characteristics by White’s class groups are presented in Table 1.
Gestational age at delivery and BMI (pre-pregnancy) were different between the White’s class
groups. The frequency of chronic hypertension and labor induction also increased with
advancing class. In women with unsuccessful VBAC, fetal indications (cord prolapsed, NRFT
and abruption) for CD were common; A1=25%, A2=29%, B=43%, C=18% and D/F/R= 57%.
Figure 1 describes the VBAC success rate by White’s class. The overall VBAC success rate
was 63.6%. VBAC success in each White’s class group was: A1=68.5% (95% CI 63.4%–
73.3%), A2=55% (95% CI 47.2%–62.7%), B=70% (95% CI 57.9%–80.4%), C=47.6% (95%
CI 25.7%–70.2%), D/F/R=12.5% (95% CI 0.3%–52.7%).
In the initial analysis, an unadjusted test of trend was performed which indicated decreased
VBAC success with advancing White’s class (p=0.004). However, when adjusted for
gestational age and labor induction, the only differences in VBAC success rates were between
Class A-1 (OR 12.7, 95 % CI 1.5–109.1) and B (OR 16.0, 95 % CI 1.8–143.5) when compared
to the D/F/R group. Maternal and neonatal complications are described in Table 2. There were
no differences in major adverse outcomes between groups.
Discussion
Our study evaluated VBAC outcomes for over 600 diabetic women and noted that VBAC
success rate was 64%, while in the non-diabetic women from the original cohort the success
rate was 73.6% (9). When examining individual White’s class groups, both Class C and D/F/
R diabetics had unadjusted VBAC success rates that were below 50%. Due to the relatively
low number of women in these categories studied (n= 29), we are unable to draw strong
conclusions. Given the lack of prior data and the clinical importance, it is relevant to offer some
discussion regarding the potential causes. Prior studies have shown a higher rate of fetal growth
restriction for women with advanced diabetes (17), and given the high rate of CD for fetal
indication in these groups, this may be one reason for the relatively low success rates. Long-
standing diabetes, and its associated vasculopathy, could predispose those patients to VBAC
failure due underlying uteroplacental insufficiency and fetal intolerance to labor. Additionally,
clinicians may be less willing to tolerate abnormal FHR patterns due to maternal disease status
or have bias towards lower threshold for cesarean due to maternal disease status. We also noted
that maternal and neonatal complications were rare and not different across White’s class
groups. Our findings are similar to Blackwell et al, who also specifically looked at VBAC
success in diabetics (13). Their results showed a higher cesarean rate in diabetics undergoing
VBAC (56.3%) compared to diabetics who did not have a history of previous cesarean (26.3%).
They also showed no significant difference in frequency of major maternal or neonatal
complications. However, they did not compare the patients in their study based on White’s
class.
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Strengths of this study include the considerable sample size, multicenter and standardized data
collection and methodology. Also, as a multicenter study, our sample population represents a
diverse group of patients. Our study has some limitations. The relatively small number of
women with White’s class D/F/R diabetes makes point estimation regarding the VBAC success
in this group difficult, as evidenced by the large confidence interval surrounding the VBAC
success rate. Also, given the overall low frequency of maternal or neonatal complications, we
did not have adequate power to detect small differences between groups. While we adjusted
for confounders such as induction of labor and gestational age at time of delivery, we did not
adjust for other clinical factors (e.g. parity, cervical status). Because this was a multicenter
study, center to center variability likely occurs. Other factors such as inter-physician variability
with regard to decision to attempt VBAC or threshold for converting from VBAC attempt to
CD was also not evaluated. Because the original study upon which this analysis was performed
was observational, no specific directives were given to practitioners with regard to those
decisions. Therefore, due to the nature of the dataset, we cannot rule out selection bias.
This study provides useful data for the counseling of diabetic women with previous CD who
are evaluating the risks and benefits of VBAC. Our study provides estimates for VBAC success
based on White’s class and indicates a relatively low rate of perinatal complications following
VBAC attempt for diabetic women. The decision for a diabetic woman to attempt VBAC
should be made jointly with her and her physician on a case by case basis.
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Vaginal birth after cesarean (VBAC) success by White’s classification. Error bars= 95%
confidence interval. White’s class A1, diet-controlled gestational diabetes; A2, insulin-
controlled gestational diabetes; B, diabetes less than 10 years in duration or age of onset after
20 years; C, diabetes of 10 to 20 years in duration or age of onset between 10 and 20 years; D/
F/R, more than 20 years in duration or age of onset less than 10 years or presence of nephropathy
or retinopathy.
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